Page 3 - Best Immunotherapy Immunotherapy: TOP 82 doctors

Univ. Prof. Dr. Wolfgang Köstler is a leading expert in breast cancer and gynecologic malignancies, with over 22 years of experience of experience in targeted cancer therapies at Wiener Privatklinik.

• Specializes in solid tumor oncology, focusing on breast and gynecologic cancers
• Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
• Active in translational research and biomarker development for precision oncology
• Published extensively in leading international journals on tumor biology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Assoc. Prof. Nail Paksoy specializes in immunotherapy at Medipol Bahçelievler Hospital, with a strong background in medical oncology and allergy-immunology.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials for immunotherapy
• Published multiple studies on cancer treatment outcomes
• Fellowship-trained at Istanbul University Oncology Institute

Dr. Salman specializes in immunotherapy for various cancers, integrating targeted therapies and cancer vaccines. He trained at prestigious institutions like Memorial Sloan Kettering Cancer Center.

• Associate Professor at Katip Çelebi University with 32 years of experience in medical oncology
• Academic visitor at Moffitt Cancer Center in Florida, USA
• Board member of Turkish Society of Medical Oncology and European Society of Medical Oncology
• Uses comprehensive genomic profiling for personalized treatment plans
• Active in clinical research and experimental medical therapies

Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University – a leader in cancer research.

• Board-certified in medical oncology since 2018
• Practices at Medical Park Antalya Hospital Complex
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University – Turkey's premier cancer research center

Dr. Ozden specializes in medical oncology with over 27 years of experience of experience in internal medicine and oncology.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced internal medicine at multiple hospitals in Turkey
• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine

Professor of Medical Oncology with over 29 years of experience of experience, specializing in advanced cancer treatments at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Associate Professor and later Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Assoc. Prof. Atakan Topcu specializes in immunotherapy and targeted therapies for solid tumors at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology
• Member of European Society for Medical Oncology (ESMO)
• Expert in geriatric oncology and cancer-related malnutrition
• Fellowship-trained in medical oncology at Bezmialem Vakıf University

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic, specializing in blood disorder treatment with over 36 years of experience of practice.

• One of the top doctors for non-Hodgkin lymphoma
• Professor with extensive academic and clinical expertise
• Focuses on immunotherapy for blood disorders

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in immunotherapy for cancer treatment.

• 15 years of experience of experience in medical oncology
• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Focuses on immunotherapy for various cancer types

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for multiple cancer types at Medipol Acibadem District Hospital.

• Trained at top institutions including Cleveland Clinic and Harvard Medical School
• ESMO Board Certified – recognized expertise in oncology
• International observership at Italy's leading breast cancer unit
• Fellowship-trained medical oncologist with broad cancer experience

Dr. Lucía González Cortijo leads one of Spain's top oncology departments, specializing in immunotherapy for breast and gynecologic cancers.

• 20+ years focused exclusively on oncology
• Principal investigator in 20+ immunotherapy clinical trials
• Trained at MD Anderson Cancer Center Madrid
• Active member of ESMO and ASCO
• Leads La Vida en Rosa Foundation for women's cancer support

Prof. Ben Boursi leads groundbreaking research on microbiome's role in cancer therapy – his work is published in Science and featured at ASCO.

• Specializes in gastrointestinal oncology at Sheba Medical Center
• Trained at University of Pennsylvania and top US cancer centers
• Founder of ECOG-ACRIN Microbiome Working Group
• Develops predictive models for early cancer detection
• Board-certified in both Internal Medicine and Medical Oncology

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

World-renowned leader in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch leads over 80 clinical trials on new treatments.

• Specializes in lymphomas and CLL with innovative treatment approaches
• Head of Hematology at IOB Institute of Oncology
• Published 100+ articles in top journals like NEJM and Nature Medicine
• Professor of Hematology at Vall d'Hebron University Hospital